News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 253–288
- Matches
- 1179
- Sources here
- 16
- Companies here
- 24
Search results
Stored financial headlines
Active search
1179 matching headlines
Ticker or company: OTECMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Sana Biotechnology faces earnings test as CAR-T program advances
Sana Biotechnology Inc. is set to report its second-quarter results on Monday, with analysts expecting a narrower loss of 15 cents per share and no revenue. Investors will be closely watching for updates on its in vivo CAR-T platform, specifically SG293, and its stem …
SANA
main company
Sharemaestro market context
Price above Trend Line
52 weeks -0.8%
Renaissance Technologies LLC Acquires Shares of 239,800 Adaptive Biotechnologies Corporation $ADPT
Renaissance Technologies LLC has acquired 239,800 shares of Adaptive Biotechnologies Corporation, valued at approximately $3.33 million, marking a new stake in the company. Institutional investors collectively hold 99.17% of Adaptive Biotechnologies. The company reported better-than-expected quarterly revenue but missed earnings estimates, while analysts maintain …
ADPT
main company
Sharemaestro market context
Trend signal active
52 weeks +90.3% · Next-week setup positive 58.0%
Puma Biotechnology (PBYI) Stock Jumps On Profit Strength As Earnings Outlook Fades
Puma Biotechnology (PBYI) saw its stock jump 9.7% after reporting strong Q2 2026 earnings, driven by NERLYNX revenue and increased net income. While current profitability and raised full-year guidance are positive, analysts project weaker earnings in the future, creating a tension between present strength …
PBYI
main company
Sharemaestro market context
Trend signal active
52 weeks +68.2%
XBiotech Inc (XBIT) Stock News Today
This article from TradingKey provides a news and analysis page for XBiotech Inc (XBIT) stock. It shows the current stock price, market cap, and links to various financial data and analytical tools. The page indicates that more news is expected soon.
XBIT
main company
Sharemaestro market context
Price below Trend Line
52 weeks -28.1% · Next-week setup negative 42.3%
Vir Biotechnology (VIR): State Street discloses 9.96M-share, 5.9% ownership position
State Street Corporation, through its investment management subsidiaries, has disclosed a beneficial ownership of 9,964,151 shares of Vir Biotechnology, Inc. common stock, which represents 5.9% of the class as of June 30, 2026. The filing indicates that all voting and dispositive authority is held …
VIR
main company
Sharemaestro market context
Trend signal ended
52 weeks +101.7%
1,915,056 Shares in Legend Biotech Corporation Sponsored ADR $LEGN Purchased by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. has acquired 1,915,056 shares of Legend Biotech Corporation (NASDAQ:LEGN) worth approximately $55.3 million, giving it a 1.03% stake. Institutional investors now own 70.89% of the company, and analysts generally have a "Moderate Buy" rating with an average price target of …
LEGN
main company
Sharemaestro market context
Price below Trend Line
52 weeks -42.7%
VERAXA Biotech Advances Antibody Therapeutics with Innovative BiTAC Platform
VERAXA Biotech is making significant strides in antibody therapeutics with its proprietary BiTAC platform, focusing on bispecific ADCs and T-cell engagers. The company's platform is designed for precision and efficacy, positioning it for potential partnerships and licensing deals in the rapidly growing market for …
VRXA
main company
Sharemaestro market context
Stored weekly price path
10 weeks -90.6% · Next-week setup negative 26.5%
Sana Biotechnology Inc (SANA) Earnings Forecast: Future EPS & Revenue Growth Estimates
Sana Biotechnology Inc (SANA) has a target price of USD 7.00, with analysts forecasting a potential upside of 151.36%. Based on ratings from 9 analysts, the consensus for SANA stock is a "Buy." The company's EPS for the previous quarter was USD -0.21, and …
SANA
main company
Sharemaestro market context
Price above Trend Line
52 weeks -0.8%
Evotec AG (NASDAQ:EVO) Receives Consensus Recommendation of "Hold" from Brokerages
Evotec AG (NASDAQ:EVO) has received a consensus "Hold" recommendation from five brokerages, with an average 12-month price target of $3.00. The ratings include two "Buy," two "Hold," and one "Sell," reflecting cautious sentiment. Recent analyst actions have shown mixed views, with some downgrades and …
EVO
main company
Sharemaestro market context
Price below Trend Line
52 weeks -46.2% · Next-week setup negative 42.6%
What Vir Biotechnology (VIR)'s Profit Swing But Earnings Miss Means For Shareholders
Vir Biotechnology (VIR) reported a significant swing to profitability in Q2 2026, with US$80.08 million in net income and sharply increased revenue of US$238.95 million. Despite this improvement, the company missed analyst expectations for both earnings and sales. The article discusses how this mixed …
VIR
main company
Sharemaestro market context
Trend signal ended
52 weeks +101.7%
Oncolytics Biotech Inc (ONCY) Earnings Forecast: Future EPS & Revenue Growth Estimates
Oncolytics Biotech Inc (ONCY) has an earnings forecast score of 7.67, ranking 274 out of 387 in the Biotechnology & Medical Research industry. Analysts have set an average price target of $5.25 for ONCY, with a high of $10.00 and a low of $3.00, …
ONCY
main company
Sharemaestro market context
Price below Trend Line
52 weeks -17.4% · Next-week setup negative 35.3%
Vir Biotechnology (NASDAQ:VIR) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen has upgraded Vir Biotechnology (NASDAQ:VIR) from a "sell" to a "hold" rating, though the overall analyst consensus remains a "Moderate Buy" with a $20.62 target price. The company recently reported strong quarterly earnings, beating EPS and revenue estimates significantly, with revenue …
VIR
main company
Sharemaestro market context
Trend signal ended
52 weeks +101.7%
PharmaCyte Biotech Inc (PMCB) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for PharmaCyte Biotech Inc (PMCB), detailing future EPS and revenue growth estimates. It includes a snapshot of the company's current stock price, market capitalization, and various financial metrics. The article also lists peer comparisons and indicates that the …
PMCB
main company
Sharemaestro market context
Price below Trend Line
52 weeks -43.2% · Next-week setup negative 43.2%
Zhengye Biotechnology Holding Ltd (ZYBT) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Zhengye Biotechnology Holding Ltd (ZYBT), focusing on future EPS and revenue growth estimates. As of August 8, 2026, ZYBT's stock closed at $1.890 USD, down 9.57%, with a market cap of $89.57 million. The page includes an …
ZYBT
main company
Sharemaestro market context
Trend signal active
52 weeks -77.7% · Next-week setup negative 43.2%
PharmaCyte Biotech Inc (PMCB) Stock News Today
This article provides current stock information for PharmaCyte Biotech Inc (PMCB), including its latest stock price, daily change, market cap, and links to financial data, analyst ratings, and news. As of the report, PMCB closed at $0.553 with a 1.37% increase, and indicated that …
PMCB
main company
Sharemaestro market context
Price below Trend Line
52 weeks -43.2% · Next-week setup negative 43.2%
Trinity Biotech PLC (TRIB) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Trinity Biotech PLC (TRIB), focusing on future EPS and revenue growth estimates. It includes current stock information, market cap, and a comparison with peer companies in the healthcare equipment sector. The data presented was last updated on …
TRIB
main company
Sharemaestro market context
Price below Trend Line
52 weeks -75.2% · Next-week setup negative 37.4%
Astrotech Corp (ASTC) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Astrotech Corp (ASTC), focusing on future EPS and revenue growth estimates. It includes a stock overview with current trading data, market capitalization, and a list of peer companies for comparison. The content also highlights sections like financial …
ASTC
main company
Sharemaestro market context
Trend signal active
52 weeks +68.2% · Next-week setup negative 25.1%
ALVO: FDA Inspection Closure And Biosimilar Resubmissions Will Drive Upside
Alvotech (ALVO) has seen its fair value reset to $5.75 from $13.83 by analysts, reflecting updated assumptions on growth and profitability, despite recent positive regulatory developments. The FDA closed its inspection of Alvotech's Reykjavik facility with a Voluntary Action Indicated classification, and the company …
ALVO
main company
Sharemaestro market context
Price above Trend Line
52 weeks -52.0% · Next-week setup negative 43.6%
Trinity Biotech PLC (TRIB) Stock News Today
This article provides current stock information for Trinity Biotech PLC (TRIB), showing its recent trading performance with a 6.79% increase. It notes that more news is expected soon regarding earnings, analyst ratings, and key developments. The page also includes financial data like market capitalization.
TRIB
main company
Sharemaestro market context
Price below Trend Line
52 weeks -75.2% · Next-week setup negative 37.4%
Evotec and Odyssey Forge AI-Powered Drug Discovery Pact Targeting Autoimmune Diseases
Evotec SE and Odyssey Therapeutics Inc. have announced a strategic AI-enabled R&D collaboration aimed at discovering new small molecule treatments for autoimmune and inflammatory diseases. The partnership combines Odyssey's disease biology expertise with Evotec's integrated discovery platform, advanced screening technologies, and proprietary compound libraries. …
EVO
main company
Sharemaestro market context
Price below Trend Line
52 weeks -46.2% · Next-week setup negative 42.6%
Law firm investigates Fortress Biotech for poss...
A law firm, Levi & Korsinsky, has initiated an investigation into Fortress Biotech, Inc. regarding potential breaches of fiduciary duties. This inquiry is focused on the company's financial management and accountability, and shareholders are encouraged to seek legal advice without cost. The investigation could …
FBIOP
main company
Sharemaestro market context
Trend signal active
52 weeks +143.5% · Next-week setup positive 56.1%